NZ332434A - Use of oligosaccharide compositions which bind one or more serotypes of cholerae toxin in the intestinal tract for the treatment of cholera and related conditions - Google Patents

Use of oligosaccharide compositions which bind one or more serotypes of cholerae toxin in the intestinal tract for the treatment of cholera and related conditions

Info

Publication number
NZ332434A
NZ332434A NZ332434A NZ33243498A NZ332434A NZ 332434 A NZ332434 A NZ 332434A NZ 332434 A NZ332434 A NZ 332434A NZ 33243498 A NZ33243498 A NZ 33243498A NZ 332434 A NZ332434 A NZ 332434A
Authority
NZ
New Zealand
Prior art keywords
cholera
intestinal tract
related conditions
serotypes
bind
Prior art date
Application number
NZ332434A
Inventor
Louis D Heerze
Glen D Armstrong
Original Assignee
Synsorb Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/460,893 external-priority patent/US5811409A/en
Application filed by Synsorb Biotech Inc filed Critical Synsorb Biotech Inc
Publication of NZ332434A publication Critical patent/NZ332434A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Use of a saccharide sequence in the preparation of a medicament, capable of being eliminated from the gastro-intestinal tract, for treating cholera and related conditions that are mediated by cholera toxin. The saccharide sequence is covalently attached to a pharmaceutically acceptable solid with inert support through a non-peptidyl compatible linker arm.
NZ332434A 1995-06-05 1998-04-18 Use of oligosaccharide compositions which bind one or more serotypes of cholerae toxin in the intestinal tract for the treatment of cholera and related conditions NZ332434A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/460,893 US5811409A (en) 1995-06-05 1995-06-05 Treatment of cholera
NZ30531898 1998-04-18

Publications (1)

Publication Number Publication Date
NZ332434A true NZ332434A (en) 2000-09-29

Family

ID=26651710

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ332434A NZ332434A (en) 1995-06-05 1998-04-18 Use of oligosaccharide compositions which bind one or more serotypes of cholerae toxin in the intestinal tract for the treatment of cholera and related conditions

Country Status (1)

Country Link
NZ (1) NZ332434A (en)

Similar Documents

Publication Publication Date Title
HUP0100507A2 (en) Polyethylene glycol-grf conjugates, site-specific preparation thereof, pharmaceutical compositions comprising thereof and their use
EP1018342A3 (en) Diagnosis and treatment of bacterial dysentery
WO1995021628B1 (en) Treatment of antibiotic associated diarrhea
JP2018507844A (en) Antibody drug conjugate
ZA968139B (en) Protein derivatives
WO1997002046A3 (en) Saccharide conjugates
RU95122664A (en) Amplification of the Vitamin B12 Absorption System Using Polymers
PL342596A1 (en) Cross-linked starch of high amylose content and with functional group as a matrix for prolonged release pharmacological agents
EP1352895A3 (en) Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
US6107282A (en) Treatment of C. difficile toxin B associated conditions
JP2002516284A5 (en)
AP2001002377A0 (en) Substituted phenoxyacetic acids.
IL117656A (en) Pharmaceutical compositions comprising a supported saccharide for the treatment of travellers' diarrhea caused by E.coli LT enterotoxin
AU4832096A (en) 10-deacetylbaccatine iii and 10-deacetyl 14beta -hydroxybaccatine iii derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
AU6921300A (en) Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof
NZ302632A (en) Treatment of traveller's diarrhea using a pharmaceutical composition containing a saccharide sequence
NZ332434A (en) Use of oligosaccharide compositions which bind one or more serotypes of cholerae toxin in the intestinal tract for the treatment of cholera and related conditions
AU3784601A (en) Oligosaccharide supports for e.g. removal of antibodies from blood
AU738081B2 (en) Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
JP2003513051A5 (en)
GR1002576B (en) Pharmaceutical compositions and a process for the preparation thereof.
JPH05331074A (en) Drug carrier
IL117564A (en) Pharmaceutical and diagnostic compositions containing lysine derivatives
NZ332532A (en) Oligosaccharide-peptide conjugate to treat diarrhea
AU1179695A (en) (vibrio cholerae) bengal serogroup-0139 capsular polysaccharide, protein conjugates thereof and antibodies induced thereby